| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 47.17 Billion | USD 91.97 Billion | 7.7% | 2024 |
FrequentlyAsked Questions
The global injection pen market is expected to grow due to increasing adoption of self-administration drug delivery devices, rising prevalence of diabetes and chronic diseases, and technological advancements in pen injectors.
According to a study, the global injection pen market size was worth around USD 47.17 Billion in 2024 and is expected to reach USD 91.97 Billion by 2034.
The global injection pen market is expected to grow at a CAGR of 7.7% during the forecast period.
North America is expected to dominate the injection pen market over the forecast period.
Leading players in the global injection pen market include Eli Lilly and Company, Sanofi, Becton, Dickinson and Company, Ypsomed Holding AG, Novo Nordisk A/S, Sun Pharmaceutical Industries Ltd., Pfizer, AstraZeneca plc, F. Hoffmann-La Roche Ltd., and Merck KGaA, among others.
The report explores crucial aspects of the injection pen market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients